QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
Format: Artikel
Sprache:English
Veröffentlicht: Elsevier 2020-08-01
Schriftenreihe:Heart Rhythm O2
Schlagworte:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
Online Zugang:http://www.sciencedirect.com/science/article/pii/S2666501820300751

Online

http://www.sciencedirect.com/science/article/pii/S2666501820300751

Ähnliche Einträge